Standardized End Point Definitions for Coronary Intervention Trials
Héctor M. García‐García(MedStar Washington Hospital Center), Patrick W. Serruys(Erasmus MC), A. Pieter Kappetein(Erasmus University Rotterdam), Andrew Farb(Memorial Hermann), Yoshinobu Onuma(Ollscoil na Gaillimhe – University of Galway), David P. Taggart(ESCP Business School), Gregg W. Stone(Cardiovascular Institute of the South), Stephan Windecker(University of Bern), Donald E. Cutlip(Baim Institute for Clinical Research), Pascal Vranckx(Jessa Hospital), William F. Fearon(Stanford University), Eugène McFadden(Skadden Arps Slate Meagher & Flom), Gerrit‐Anne van Es(Centre Hospitalier Universitaire de Caen Normandie), Marie‐Angèle Morel(Unknown), Bram Zuckerman(United States Food and Drug Administration), John A. Spertus(Saint Luke's Health System), Mitchell W. Krucoff(Duke University), Roxana Mehran(Mount Sinai Hospital)
Cited by 310
Related Papers
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
|European Heart Journal|2015|8.3k
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
Clinical End Points in Coronary Stent Trials
|Circulation|2007|5.4k
A Comparison of Balloon-Expandable-Stent Implantation with Balloon Angioplasty in Patients with Coronary Artery Disease
|New England Journal of Medicine|1994|4.5k
A Randomized Comparison of a Sirolimus-Eluting Stent with a Standard Stent for Coronary Revascularization
|New England Journal of Medicine|2002|4k